SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Optomedical
Optomedical Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Optomedical Spółka z Ograniczoną Odpowiedzialnością
Optomedical Spółka z Ograniczoną Odpowiedzialnością (KRS 0000990771, NIP 7812039875) is a Polish company, headquartered in Poznań, Wielkopolskie voivodeship. OPTOMEDICAL operates in: Specialist medical practice activities (PKD 86.22.Z). Industry: Healthcare. The company has been listed in the National Court Register since September 7, 2022. OPTOMEDICAL's most recently reported net revenue was 486.6 K PLN for 2024.
Negative equity
Negative equity in 1 of 3 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
86.22.ZSpecialist medical practice activities
Other activities
Credibility rating
33 / 100
Poor credibility
Insolvency risk
Low
Elevated threat
Closure risk
25
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/4 yrs
Board changes
0
0/4 yrs
PKD changes
0
0/4 yrs
Name changes
0
0/4 yrs
Data from 4 years of registry activity.
Payment reliability score from 2022–2024
Current: E (33/100)
Trend: improving (+9.6 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Standard limit from 2022–2024
Current: 6.4 K PLN
Safe: 1.3 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
September 7, 2022
3 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
POZNAŃ
WIELKOPOLSKIE
Primary PKD
86.22.Z
Specialist medical practice activities
Share capital
10.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
3 people
Filed years
3 years
2022–2024 · profitable: 1/3
Registry entries
7
latest: December 7, 2025
Risk signals
Revenue
486.6 K PLN
2024
Net profit
-10.2 K PLN
2024
Assets
77.2 K PLN
2024
Equity
N/A
2024
EBITDA
N/A
2024
no depreciation data
Valuation
184.9 K PLN
Low confidence
Low confidence
Rate business credibility - Optomedical.
No ratings

News
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.

Explainer
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
Latest reporting year
2024
Available years
3
Filing entries
0
7 historical registry entries for Optomedical
Identifier change
PO.VIII NS-REJ.KRS/23223/22/282/NIP
Identifier change
PO.VIII NS-REJ.KRS/23223/22/282/REGON
Filing documents submitted (2 documents)
Filing document
Filing document
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
OPTOMEDICAL's board has 3 members.
Competing companies or those operating in the same market segment as Optomedical (in Poznań, industry: Healthcare).
POZNAŃ· Healthcare
Revenue 2024: 68.4 M PLN
KONIN· Healthcare
Revenue 2024: 67.1 M PLN
POZNAŃ· Healthcare
Revenue 2024: 46.3 M PLN
GNIEZNO· Healthcare
Revenue 2024: 29.7 M PLN
POZNAŃ· Healthcare
Revenue 2024: 22.0 M PLN
POZNAŃ· Healthcare
Revenue 2024: 19.8 M PLN